Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. MustGrow Biologics's long-term debt to total assests ratio for the quarter that ended in Jun. 2026 was 0.02.
MustGrow Biologics's long-term debt to total assets ratio
declined
from Jun. 2025 (0.46) to Jun. 2026 (0.02).
It may suggest that MustGrow Biologics is progressively becoming less dependent on debt to grow their business.
LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.
MustGrow Biologics LT-Debt-to-Total-Asset Related Terms
MustGrow Biologics LT-Debt-to-Total-Asset Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's LT-Debt-to-Total-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MustGrow Biologics (FRA:0C0) has a LT-Debt-to-Total-Asset of 0.02 as of Jun. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on MustGrow Biologics and its competitors.
Is MustGrow Biologics' LT-Debt-to-Total-Asset too high?
MustGrow Biologics' current LT-Debt-to-Total-Asset is 0.02. Overall, MustGrow Biologics has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' LT-Debt-to-Total-Asset compare to CTVA and CF?
MustGrow Biologics' LT-Debt-to-Total-Asset of 0.02 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for an Agriculture company?
A good LT-Debt-to-Total-Asset depends on the Agriculture industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on MustGrow Biologics and its competitors. MustGrow Biologics's current LT-Debt-to-Total-Asset is 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
Based on GuruFocus' analysis, MustGrow Biologics (FRA:0C0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.47, compared to a current price of €0.23 — trading 51.5% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.02. MustGrow Biologics' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For MustGrow Biologics (FRA:0C0), the current LT-Debt-to-Total-Asset is 0.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MustGrow Biologics (FRA:0C0) Overvalued in 2026?
Based on GuruFocus' analysis, MustGrow Biologics stock appears to be undervalued.
The current stock price of €0.23 is trading 51.5% below its estimated GF Value™ of €0.47.
GuruFocus considers MustGrow Biologics to be Possible Value Trap.
Key valuation signals for FRA:0C0:
LT-Debt-to-Total-Asset: 0.02
GF Value™: €0.47 vs. price of €0.23 (51.5% below fair value)
No single metric tells the full story. See the FRA:0C0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
28GF Score
Get the complete analysis for FRA:0C0
LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0C0 has been successfully added to your 
